Serum Institute seeks approval for Oxford COVID Vaccine, Covishield

(STL.News) The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorization for the Oxford COVID-19 vaccine ‘Covishield’ in the country.

YouTube video provided courtesy of WION News

STL.News References:

  1. YouTube

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.